Global Summit on Improving the Bioavailability of Medicines 2022: two-day online program

company logo

Dublin, March 08, 2022 (GLOBE NEWSWIRE) — The “Global Summit on Improving Drug Bioavailability 2022” conference has been added to from ResearchAndMarkets.com offer.

Are you responsible for improving drug performance, bioavailability and patient adherence? Would you like to discover new strategies to reduce dosage, costs and reduce time to market of products?

Check out the 2022 Global Summit on Improving Drug Bioavailability program agenda and walk away with 2+ years of novel drug formulation and bioavailability improvement strategies. Learn directly from over 30 senior drug bioavailability pioneers and network with over 120 senior drug development innovators next May in Philadelphia, Pennsylvania.

The 2022 2-day program features the latest in industry formulation and delivery technologies to improve solubility and maximize bioavailability. The 2022 Summit will share cutting-edge research on the development, characterization and manufacturing of formulations spanning multiple modalities.

  • Precision Medicine and Healthcare Delivery

  • Rational formulation design for poorly soluble compounds

  • In-vivo – in-vitro correlation

  • Solution behavior of amorphous solid dispersions

  • Nanosuspension to improve bioavailability

  • Early Formulation Screening in Drug Discovery

  • 3D printing for biopharma

  • Improving patient adherence via drug administration

  • Innovative strategies around drug/device combinations

2021 speakers included:

Manish Gupta, PhD
Senior Director, Pharmaceutical Development – Sterile
GlaxoSmithKline

Dedong Wu, PhD
Senior Scientist, Solid State
Astra Zeneca

Arijit Chakravarty, PhD
Chief Executive Officer
Fractal therapy

Rick Panicucci, PhD
Senior Vice President, CMC
Therapeutic QED

Saji Vijayan, PhD
Vice President – R&D Strategy
Endo Pharmaceuticals

Sune Anderson, Ph.D.
Senior Scientist, Spray Drying
Johnson & Johnson

Susan Rosenbaum
Founder, CEO
Laurent Science

Stephen Tindal, PhD
Director, Science and Technology
Catalent Pharmaceutical Solutions

Melanie Marota, PhD
Associate Principal Investigator, Pharmaceutical Sciences
Merck & Co.

Eric Munson, PhD
Patrick DeLuca Endowed Professor of Pharmaceutical Technology, Department of Pharmaceutical Sciences
Purdue University

Di Wu, PhD
Senior Scientist, Formulation Development
Merck & Co.

Stephen Stern, PhD
Director of Research and Development, Head of the Pharmacology and Toxicology Section
Nanotechnology Characterization Laboratory

Dabing Chen, Ph.D.
Senior Principal Scientist
Boehringer Ingelheim

Xin Liu, Ph.D.
Associate Director of Pharmaceutical Product Development
Triasek

Christopher Nuboldt
Principal Investigator
INVITE GmbH

Sudhakar Garad, PhD
Global Head of Chemical and Pharmaceutical Profiling
Novartis

For more information about this conference, visit https://www.researchandmarkets.com/r/nkj0rv

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

Karen O. Fielding